Ligufalimab, CAS 2428381-55-7

Product Description: Ligufalimab (AK 117) is a humanized IgG4 anti-CD47 monoclonal antibody. Ligufalimab does not induce RBC hemagglutination, and induces phagocytosis. Ligufalimab shows anti-tumor activity[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Qu T, et al. Ligufalimab, a novel anti-CD47 antibody with no hemagglutination demonstrates both monotherapy and combo antitumor activity. J Immunother Cancer. 2022 Nov;10(11):e005517.

CAS Number: 2428381-55-7

Molecular Weight: N/A

Compound Purity: 98.81

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Interleukin Related

• Artikelnummer: MEXHY-P99706-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99706-1
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated